Published on 8 Nov 2024 on GuruFocus.com · via Yahoo Finance
Vistagen Therapeutics Inc (VTGN) Q2 2025 Earnings Call Highlights: Navigating...
Despite increased expenses and net loss, Vistagen Therapeutics Inc (VTGN) advances its neuroscience...
NASDAQ.VTGN price evolution
Want to become a better investor?
Start tracking your investments with Statfolio
Sign up for free